Coronary vasospasm: A case report and review of the literature

Canadian Journal of Cardiology

Volumn 21, Issue 11, 2005, Pages 953-957

  Van Spall, Harriette G C ^a   Overgaard, Christopher B ^a   Abramson, Beth L ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Coronary vasocontriction; Coronary vasospasm; Prinzmetal's angina; Variant angina

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; HEPARIN; LONG ACTING DRUG; NICORANDIL; NITRIC ACID DERIVATIVE; PRAZOSIN; TROGLITAZONE;

AGED; ANGIOCARDIOGRAPHY; ARTERY CONSTRICTION; ARTICLE; CASE REPORT; CORONARY ARTERY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; CORONARY STENT; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG INDICATION; DRUG MECHANISM; DRUG MEGADOSE; FREQUENCY ANALYSIS; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; PATHOGENESIS; PATHOPHYSIOLOGY; PROGNOSIS; ST SEGMENT ELEVATION; TREATMENT OUTCOME; VASODILATATION;

AGED; CALCIUM CHANNEL BLOCKERS; CORONARY ANGIOGRAPHY; CORONARY VASOSPASM; ELECTROCARDIOGRAPHY; HUMANS; MALE; NITRATES; STENTS; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 27744543574     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S. Circadian variation of exercise capacity in patients with Prinzmetal's variant angina: Role of exercise-induced coronary arterial spasm. Circulation 1979;59:938-48.
2. Prinzmetal M, Kennamer R, Merliss R, Wada W, Bor N. Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med 1959;27:375-88.
3. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: Differences between Japanese and Caucasian patients. J Am Coll Cardiol 1999;33:1442-52.
4. Keller KB, Lemberg L. Prinzmetal's angina. Am J Crit Care 2004;13:350-4.
5. Lange RA, Cigarroa RG, Yancy CW Jr, et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med 1989;321:1557-62.
6. Yasue H, Kugiyama K. Coronary spasm: Clinical features and pathogenesis. Intern Med 1997;36:760-5.
7. Ozaki Y, Keane D, Serruys PW. Fluctuation of spastic location in patients with vasospastic angina: A quantitative angiographic study. J Am Coll Cardiol 1995;26:1606-14.
8. Yamagishi M, Miyatake K, Tamai J, Nakatani S, Koyama J, Nissen SE. Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. J Am Coll Cardiol 1994;23:352-7.
9. Mintz GS, Painter JA, Pichard AD, et al. Atherosclerosis in angiographically "normal" coronary artery reference segments: An intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995;25:1479-85.
10. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993;328:1659-64.
11. Chauhan A, Mullins PA, Taylor G, Petch MC, Schofield PM. Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms. Eur Heart J 1997;18:60-8.
12. Ludmer PL, Selwyn AF, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-51.
13. Yasue H, Horio Y, Nakamura N, et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: Possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986;74:955-63.
14. Okumura K, Yasue H, Matsuyama K, et al. Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol 1988;12:883-8.
15. Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol 1999;34:631-8.
16. Mohri M, Koyanagi M, Egashira K, et al. Angina pectoris caused by coronary microvascular spasm. Lancet 1998;351:1165-9.
17. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993;87:76-9.
18. Minor RL Jr, Scott BD, Brown DD, Winniford MD. Cocaine-induced myocardial infarction in patients with normal coronary arteries. Ann Intern Med 1991;115:797-806.
19. Vandergoten P, Benit E, Dendale P. Prinzmetal's variant angina: Three case reports and a review of the literature. Acta Cardiol 1999;54:71-6.
20. Lange RL, Reid MS, Tresch DD, Keelan MH, Bernhard VM, Coolidge G. Nonatheromatous ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure. Circulation 1972;46:666-78.
21. Kozeny GA, Ragona BP, Bansal VK, et al. Myocardial infarction with normal results of coronary angiography following diltiazem withdrawal. Am J Med 1986;80:1184-6.
22. Shoemaker LK, Arora U, Rocha Lima CM. 5-Fluorouracil-induced coronary vasospasm. Cancer Control 2004;11:46-9.
23. Mariani G, Giaccon G, Mastore M. Acute severe coronary spasm associated with initial first dose of 5-fluorouracil chemotherapy. Ital Heart J 2003;4:568-70.
24. Song JK, Park SW, Kang DH, et al. Safety and clinical impact of ergonovine stress echocardiography for diagnosis of coronary vasospasm. J Am Coll Cardiol 2000;35:1850-6.
25. Schwartz L, Bourassa MG. Evaluation of patients with chest pain and normal coronary angiograms. Arch Intern Med 2001;161:1825-33.
26. Suzuki Y, Tokunaga S, IkeguchI S, et al. Induction of coronary artery spasm by intracoronary acetylcholine: comparison with intracoronary ergonovine. Am Heart J 1992;124:39-47.
27. Nakao K, Ohgushi M, Yoshimura M, et al. Hyperventilation as a specific test for diagnosis of coronary artery spasm. Am J Cardiol 1997;80:545-9.
28. Nakao K, Ohgushi M, Yoshimura M, et al. Hyperventilation as a specific test for the diagnosis of coronary artery vasospasm. Am J Cardiol 1997;80:545-9.
29. Tzivoni D, Karen A, Benhorin J, et al. Prazocin therapy for refractory variant angina. Am Heart J 1983;105:262-5.
30. Kaski JC. Management of vasospastic angina - role of nicorandil. Cardiovasc Drugs Ther 1995;9(Suppl 2):221-7.
31. Murakami T, Mizuno S, Shoat K, et al. Effects of troglitazone on frequency of coronary vasospastic-induced angina pectoris in patients with diabetes mellitus. Am J Cardiol 1999;84:92-4.
32. Robertson RM, Wood AJ, Vaughn WK, Robertson D. Exacerbation of vasotonic angina pectoris by propranolol. Circulation 1982;65:281-5.
33. Bory M, Pierron F, Panagides D, Bonnet JL, Yvorra S, Desfossez L. Coronary artery spasm in patients with normal or near normal coronary arteries. Long-term follow-up of 277 patients. Eur Heart J 1996;17:1015-21.
34. Freedman SB, Richmond DR, Alwyn M, Kelly DT. Late follow-up (41 to 102 months) of medically treated patients with coronary artery spasm and minor atherosclerotic coronary obstructions. Am J Cardiol 1986;57:1261-3.
35. Tanabe Y, Itoh E, Suzuki K, et al. Limited role of coronary angioplasty and stenting in coronary spastic angina with organic stenosis. J Am Coll Cardiol 2002;39:1120-6.
36. Khatri S, Webb JG, Carere RG, Dodek A. Stenting for coronary artery spasm. Catheter Cardiovasc Interv 2002;56:16-20.
37. Gaspardone A, Tomai F, Versaci F, et al. Coronary artery stent placement in patients with variant angina refractory to medical treatment. Am J Cardiol 1999;84:96-8.
38. Lopez JA, Angelini P, Leachman DR, Lufschanowski R. Gianturco-Roubin stent placement for variant angina refractory to medical treatment. Cathet Cardiovasc Diagn 1994;33:161-5.
39. Rodgers GP, Raizner AE, Cromeens DM, et al. Coronary spasm induced by stent implantation. J Am Coll Cardiol 1989;13:194A
40. Rabinowitz A, Dodek A, Carere RG, Webb JG. Stenting for treatment of coronary vasospasm. Cathet Cardiovasc Diagn 1996;39:372-5.
41. Bertrand ME, LaBlanche JM, Thieuleux FA, Fourrier JL, Traisnel G, Asseman P. Comparative results of percutaneous transluminal coronary angioplasty in patients with dynamic versus fixed coronary stenosis. J Am Coll Cardiol 1986;8:504-8.
42. Tashiro H, Shimokawa H, Koyanagi S, Takeshita A. Clinical characteristics of patients with spontaneous remission of variant angina. Jpn Circ J 1993;57:117-22.
43. Ozaki Y, Takatsu F, Osugi J, et al. Long-term study of recurrent vasospastic angina using coronary angiograms during ergonovine provocation tests. Am Heart J 1992;123:1191-6.
44. Walling A, Waters DD, Miller DD, Roy D, Pelletier GB, Theroux P. Long-term prognosis of patients with variant angina. Circulation 1987;76:990-7.